Industry News
March 12, 2010HGS, BioInvent ink antibody deal
March 12, 2010MiddleBrook plots major job cuts as CEO exits
March 12, 2010Arena will launch lorcaserin with or without partner
March 12, 2010Pfizer stops another figitumumab trial
March 12, 2010Aveo proves investors still lack appetite for biotech IPOs
March 12, 2010Genetix raises $35M to advance gene therapies
March 11, 2010Merck joins consortium on vax plant
March 11, 2010Aveo Pharma delays IPO, at least briefly
March 11, 2010Bay Area biotech blueprints $100M China biologics hub
March 11, 2010BioSante shares surge as cancer vax performs in small study
March 11, 2010Basilea mounts last-ditch effort to gain quick ceftobiprole OK
March 11, 2010Pioneering personal sequencing projects unveil disease triggers
March 10, 2010Amylin, Lilly gear up for big FDA ruling
March 10, 2010Cytokinetics gets orphan drug status for ALS drug
March 10, 2010Neuropharm mulls voluntary liquidation as it waits for deal
March 10, 2010EKR names interim president, CEO
March 10, 2010Novartis offers $955M deal to snare Transgene drug option
March 10, 2010Biotech VCs, Big Pharma stepping outside the comfort zone
March 9, 2010In 9-3 vote, expert panel backs InterMune's pirfenidone
March 9, 2010Abbott buys Facet Biotech for $450M
March 9, 2010Tocagen raises $7.8M; ISTA gets PDUFA date;
March 9, 2010AutoImmune calls it quits
March 9, 2010Cellzome partners with GSK on inflammatory diseases
March 9, 2010Who's the next biotech buyout target?
March 9, 2010InterMune trading halted on panel review
March 9, 2010'Externalization' takes center stage at Bio-Europe Spring
March 9, 2010Ark in sales talks after regulators demand new trial
March 9, 2010Exelixis chops 270 jobs in restructuring
March 8, 2010ExonHit, bioMerieux nix colon cancer program
March 8, 2010FDA OKs Cell Therapeutics' manufacturing plant